Patents by Inventor Jerôme Aubert

Jerôme Aubert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
    Publication number: 20100247468
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Application
    Filed: September 21, 2009
    Publication date: September 30, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Clary, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • METHODS OF MODULATING PPAR GAMMA-TYPE RECEPTORS
    Publication number: 20100099689
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Application
    Filed: September 18, 2009
    Publication date: April 22, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence CLARY, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • Methods for activating PPAR gamma-type receptors
    Publication number: 20100035988
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: October 9, 2009
    Publication date: February 11, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Modulators of HSD17b7 for treating acne or hyperseborrhea
    Publication number: 20100028879
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of hydroxysteroid (17-beta) dehydrogenase type 7, and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or in vitro prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: February 4, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Michel Rivier, Van Luu-The, Ezequiel L. Calvo, Jerome Aubert, Sophie Deret, Johannes Voegel
  • Modulators of SC4MOL for treating acne or hyperseborrhea
    Publication number: 20100021892
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of sterol-C4-methyl oxidase (SC4MOL), and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: January 28, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Mohamed El-Alfy, Van Luu-The, Ezequiel L. Calvo, Jerome Aubert, Isabelle Carlavan, Sophie Deret, Johannes Voegel
  • Modulators of lanosterol synthetase for treating acne or hyperseborrhea
    Publication number: 20100021893
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of lanosterol synthetase (LSS), and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: January 28, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Mohamed El-Alfy, Van Luu-The, Ezequiel L. Calvo, Jerome Aubert, Pascal Collette, Johannes Voegel
  • Biaromatic compounds which activate PPAR?-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7626054
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: December 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Compounds that modulate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7625914
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: December 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • Modulators of scarb-1 for treating acne or hyperseborrhea
    Publication number: 20090246776
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of the SCARB-1 receptor, and the use of modulators of the expression or activity of this receptor for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: October 1, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Isabelle Carlavan, Pascal Collette, Ezequiel L. Calvo, Jerome Aubert, Johannes Voegel
  • 5-HT4 partial agonist pharmaceutical compositions
    Publication number: 20090104263
    Abstract: A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a disintegrant in an amount of less than 15% by weight a glidant and a lubricant,
    Type: Application
    Filed: October 7, 2008
    Publication date: April 23, 2009
    Inventors: Jerome Aubert, Christian Vitzling
  • Novel biaromatic compounds which activate PPARy-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20070112070
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: November 3, 2006
    Publication date: May 17, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060148862
    Abstract: Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.
    Type: Application
    Filed: December 20, 2005
    Publication date: July 6, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Laurence Clary, Etienne Thoreau, Michel Rivier, Jerome Aubert, Laurent Chantalat, Johannes Voegel
  • 5-Ht4partial agonist pharmaceutical compositions
    Publication number: 20050106236
    Abstract: A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a disintegrant in an amount of less than 15% by weight a glidant and a lubricant.
    Type: Application
    Filed: December 20, 2002
    Publication date: May 19, 2005
    Inventors: Jerome Aubert, Christian Vitzling